Date published: 2025-10-27

1-800-457-3801

SCBT Portrait Logo
Seach Input

(–)-Nutlin-3 (CAS 675576-98-4)

4.0(1)
Write a reviewAsk a question

See product citations (2)

Alternate Names:
Nutlin-3a; (−)-4-(4,5-Bis(4-chlorophenyl)-2-(2-isopropoxy-4-methoxyphenyl)-4,5-dihydro-1H-imidazole-1-carbonyl)piperazin-2-one
Application:
(–)-Nutlin-3 is an inhibitor of p-53-MDM2 interaction
CAS Number:
675576-98-4
Purity:
≥98%
Molecular Weight:
581.49
Molecular Formula:
C30H30Cl2N4O4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

(−)-Nutlin-3 is a cis-imidazoline analog, which inhibits the interaction between the proteins p53 and MDM2. It is known that (−)-Nutlin-3 appears as the first peak during chiral purification of racemic Nutlin-3 (sc-45061). Studies indicate that (−)-Nutlin-3 amplifies the expression of p53 regulated genes and shows antiproliferative effects in cells containing functional p53. (−)-Nutlin-3 is a useful tool in studying the regulation of tumors in cells.


(–)-Nutlin-3 (CAS 675576-98-4) References

  1. Drug discovery and p53.  |  Lane, DP. and Hupp, TR. 2003. Drug Discov Today. 8: 347-55. PMID: 12681938
  2. Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy.  |  Tovar, C., et al. 2006. Proc Natl Acad Sci U S A. 103: 1888-93. PMID: 16443686
  3. [In-vivo activation of the p53 pathway by small-molecule antagonists of MDM2].  |  Shinohara, T. and Uesugi, M. 2007. Tanpakushitsu Kakusan Koso. 52: 1816-7. PMID: 18051440
  4. Nutlin-3 induces BCL2A1 expression by activating ELK1 through the mitochondrial p53-ROS-ERK1/2 pathway.  |  Lee, SY., et al. 2014. Int J Oncol. 45: 675-82. PMID: 24867259
  5. Sequential cancer mutations in cultured human intestinal stem cells.  |  Drost, J., et al. 2015. Nature. 521: 43-7. PMID: 25924068
  6. Nutlin-3, an Antagonist of MDM2, Enhances the Radiosensitivity of Esophageal Squamous Cancer with Wild-Type p53.  |  He, T., et al. 2018. Pathol Oncol Res. 24: 75-81. PMID: 28341911
  7. Oridonin synergizes with Nutlin-3 in osteosarcoma cells by modulating the levels of multiple Bcl-2 family proteins.  |  Wang, XH., et al. 2017. Tumour Biol. 39: 1010428317701638. PMID: 28618955
  8. Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis.  |  Lee, DM., et al. 2017. Exp Mol Med. 49: e365. PMID: 28798402
  9. Synergistic effect of nutlin-3 combined with aspirin in hepatocellular carcinoma HepG2 cells through activation of Bcl-2/Bax signaling pathway.  |  Miao, R., et al. 2018. Mol Med Rep. 17: 3735-3743. PMID: 29286113
  10. Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.  |  Chen, H., et al. 2018. EBioMedicine. 36: 252-265. PMID: 30274821
  11. The effects of Nutlin-3 on morphology, cellular proliferation, and apoptosis in rat primary mesenchymal stem cells.  |  Bajelan, B., et al. 2019. J Cell Physiol. 234: 11424-11430. PMID: 30478967
  12. Dual-channel surface plasmon resonance monitoring of intracellular levels of the p53-MDM2 complex and caspase-3 induced by MDM2 antagonist Nutlin-3.  |  Wu, L., et al. 2019. Analyst. 144: 3959-3966. PMID: 31134974
  13. Resistance of human primary mesenchymal stem cells to cytotoxic effects of nutlin-3 in vitro.  |  Bajelan, B., et al. 2020. J Cell Biochem. 121: 788-796. PMID: 31452266

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

(–)-Nutlin-3, 1 mg

sc-222086
1 mg
$120.00

(–)-Nutlin-3, 5 mg

sc-222086A
5 mg
$215.00